AtaiBeckley (ATAI) Net Margin (2021 - 2026)

AtaiBeckley (ATAI) recorded quarterly Net Margin of 3121.8% in Q1 2026, down 83.66% quarter-over-quarter from 1699.74% in Q1 2025, and down 142206.0% on a YoY basis from N/an in Q1 2025.

AtaiBeckley (ATAI) Net Margin (2021 - 2026) Analysis & Trends

AtaiBeckley has disclosed Net Margin across 5 years of filings, most recently posting 8154.07% for Q3 2025.

  • Net Margin for Q3 2025 came in at 8154.07%, up 5756093.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 5080.46% (up 3377241.0% YoY), and the FY2024 annual result was 48463.96%, down 3565377.0% from the prior year.
  • Net Margin was 3121.8% for Q1 2026 at AtaiBeckley, down from 1699.74% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1699.74% in Q1 2025 to a low of 3121.8% in Q1 2026.
  • The 5-year median for Net Margin is 21266.7% (2022), against an average of 56261.37%.
  • Across the five-year window, Net Margin jumped 19205101 bps in 2023 and tumbled 22302778 bps in 2024, its largest moves.
  • AtaiBeckley's Net Margin stood at 22667.83% in 2021, then slumped by 423 bps to 118450.0% in 2022, then gained by 14 bps to 101622.22% in 2023, then slumped by 219 bps to 324650.0% in 2024, then soared by 97 bps to 8154.07% in 2025.
  • The last three Net Margin figures came in at 8154.07% (Q3 2025), 3856.61% (Q2 2025), and 1699.74% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - -3,121.80%

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,121.80%
Sep 30, 2025 -8,154.07%
Jun 30, 2025 -3,856.61%
Mar 31, 2025 -1,699.74%
Mar 31, 2025 -1,699.74%
Dec 31, 2024 -324,650.00%
Sep 30, 2024 -65,715.00%
Jun 30, 2024 -20,993.41%
Dec 31, 2023 -101,622.22%
Sep 30, 2023 50,855.17%
Jun 30, 2023 -19,210.47%
Mar 31, 2023 -89,554.05%
Dec 31, 2022 -118,450.00%
Sep 30, 2022 -141,195.83%
Jun 30, 2022 -21,540.00%
Dec 31, 2021 -22,667.83%
Sep 30, 2021 -11,713.53%
Mar 31, 2021 -14.37%